These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 725323)

  • 1. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS
    Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
    Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.
    Warrell RP; Chou TC; Gordon C; Tan C; Roberts J; Sternberg SS; Philips FS; Young CW
    Cancer Res; 1980 Dec; 40(12):4546-51. PubMed ID: 7438089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H; Roberts J
    Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract]   [Full Text] [Related]  

  • 9. Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase-asparaginases.
    Schmid FA; Roberts J
    Cancer Chemother Rep; 1974; 58(6):829-40. PubMed ID: 4447925
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
    Holcenberg JS; Tang E; Dolowy WC
    Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrogen utilization in mice bearing Ehrlich ascites tumor treated with Acinetobacter glutaminase-asparaginase.
    Kien CL; Holcenberg JS
    Cancer Res; 1981 Jun; 41(6):2051-5. PubMed ID: 7237413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme therapy of cancer, future studies.
    Holcenberg JS
    Cancer Treat Rep; 1981; 65 Suppl 4():61-5. PubMed ID: 7346158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):317-27. PubMed ID: 7244366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of succinylated Acinetobacter glutaminase-asparaginase treatment on an acute myeloid leukemia in the rat (BNML).
    Sonneveld P; Holcenberg JS; van Bekkum DW
    Eur J Cancer (1965); 1979 Aug; 15(8):1061-3. PubMed ID: 292598
    [No Abstract]   [Full Text] [Related]  

  • 15. Amino acid utilization and urine protein excretion in children treated with succinylated Acinetobacter glutaminase-asparaginase.
    Kien CL; Holcenberg JS
    Cancer Res; 1981 Jun; 41(6):2056-62. PubMed ID: 7016307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induced synthesis of asparaginase and glutaminase by Pseudomonas sp].
    Evseev LP; Nikolaev AIa; Eremenko VV; Mardashev SR
    Biokhimiia; 1967; 32(4):873-5. PubMed ID: 5592304
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity of cultured pancreatic carcinoma cells to Acinetobacter glutaminase-asparaginase.
    Wu MC; Arimura GK; Holcenberg JS; Yunis AA
    In Vitro; 1982 Sep; 18(9):750-4. PubMed ID: 7173949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue nitrogen-sparing effect of high protein diet in mice with or without ascites tumor treated with Acinetobacter glutaminase-asparaginase.
    Kien CL; Anderson AJ; Holcenberg JS
    Cancer Res; 1985 Oct; 45(10):4876-82. PubMed ID: 4027974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
    Abuchowski A; van Es T; Palczuk NC; McCoy JR; Davis FF
    Cancer Treat Rep; 1979 Jun; 63(6):1127-32. PubMed ID: 466651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.